OC.12.3 SPOSIB SB2 – A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH INFLIXIMAB BIOSIMILAR SB2 (FLIXABI®): INTERIM ANALYSIS. (25th March 2019) - Macaluso, F.S.; Cappello, M.; Giuffrida, E.; Fries, W.; Centritto, A.; Privitera, A.C.; Inserra, G.; Vassallo, R.; Magnano, A.; Vinci, E.; Garufi, S.; Ventimiglia, M.; et al.